Skip to main content
Shenzhen Salubris Pharmaceuticals Co., Ltd. logo

Shenzhen Salubris Pharmaceuticals Co., Ltd. — Investor Relations & Filings

Ticker · 002294 ISIN · CNE100000FW8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,655 across all filing types
Latest filing 2025-12-09 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002294

About Shenzhen Salubris Pharmaceuticals Co., Ltd.

https://www.salubris.com

Shenzhen Salubris Pharmaceuticals Co., Ltd. is a research-driven enterprise focused on the development, manufacturing, and commercialization of innovative drugs and medical devices. The company specializes in therapeutic areas including cardiovascular diseases, chronic kidney disease, and metabolic disorders. Its product portfolio features proprietary treatments such as Allisartan Isoproxil for hypertension and Clopidogrel Bisulfate for anti-platelet therapy. Salubris maintains an integrated value chain encompassing research and development, active pharmaceutical ingredient production, and finished dosage manufacturing. The firm emphasizes innovation through its dedicated R&D centers and strategic focus on biologics and small molecule drugs, aiming to provide comprehensive clinical solutions for chronic conditions.

Recent filings

Filing Released Lang Actions
公司章程（2025年12月）
Governance Information Classification · 95% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Shenzhen Salubris Pharmaceuticals Co., Ltd., dated December 2025. It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, share issuance, shareholder meetings, voting procedures, and other governance-related rules. There is no indication that this is an annual report, financial statement, or any other type of financial disclosure. Instead, it is a governance document that sets out the internal rules and regulations of the company. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial and contains detailed governance content, not just an announcement or summary, so it is not an RPA or RNS. Hence, the classification is CGR with high confidence.
2025-12-09 Chinese
董事会薪酬与考核委员会工作细则（2025年12月）
Governance Information Classification · 95% confidence The document is titled '董事会薪酬与考核委员会工作细则' which translates to 'Board Remuneration and Assessment Committee Working Rules'. It details the structure, responsibilities, and procedures of the board's remuneration and assessment committee, including how it manages compensation and performance evaluation of directors and senior management. There are no financial statements, earnings data, or regulatory filings. The content is focused on governance practices related to remuneration and assessment within the board structure. This matches the description of Governance Information (CGR), which covers internal rules, board structure, and governance practices. The document length is 3352 characters, which is sufficient for a detailed governance report rather than a brief announcement or notice. Therefore, the appropriate classification is CGR with high confidence.
2025-12-09 Chinese
董事会提名委员会工作细则（2025年12月）
Governance Information Classification · 100% confidence The document is titled '董事会提名委员会工作细则' which translates to 'Board Nomination Committee Working Rules'. It details the structure, responsibilities, procedures, and rules governing the Board Nomination Committee of the company. It does not contain financial data, earnings, audit information, or any report of financial performance. Instead, it focuses on governance practices related to board nominations and management appointments. This fits the description of a Governance Information report, which details the company's internal rules, board structure, and governance practices. The document length is 3128 characters, which is sufficient for a detailed governance report. Therefore, the appropriate classification is Governance Information (CGR).
2025-12-09 Chinese
董事会秘书工作制度（2025年12月）
Governance Information Classification · 95% confidence The document is titled '董事会秘书工作制度' which translates to 'Board Secretary Work System'. It outlines the duties, qualifications, appointment, and responsibilities of the Board Secretary in accordance with company law and stock exchange rules. The content focuses on governance practices, internal rules, and the role of the board secretary rather than financial data, earnings, or shareholder votes. There is no indication of financial statements, audit results, or meeting minutes. This document fits the description of Governance Information (CGR), which details the company's internal rules, board structure, and governance practices.
2025-12-09 Chinese
内部问责制度（2025年12月）
Governance Information Classification · 95% confidence The document is titled '内部问责制度' (Internal Accountability System) and details the company's internal accountability rules, responsibilities, and procedures for board members and senior management. It outlines the scope of accountability, procedures for handling violations, and disciplinary measures. There is no financial data, no mention of financial results, no regulatory filings, no voting results, no capital changes, no legal proceedings, or any other typical financial or regulatory report content. The document is a governance-related policy issued by the company's board. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2025-12-09 Chinese
年报信息披露重大差错责任追究制度（2025年12月）
Governance Information Classification · 95% confidence The document is titled '年报信息披露重大差错责任追究制度' which translates to 'Annual Report Information Disclosure Major Error Accountability System'. It outlines the company's internal policies and procedures for accountability related to major errors in annual report disclosures, including definitions, standards for identifying major accounting errors, procedures for correction, and responsibility assignment. It does not contain actual financial data or the annual report itself but rather a governance and compliance policy document related to annual report disclosures. The document is relatively short (4221 characters) and reads like an internal governance or regulatory compliance document rather than a full annual report or audit report. Therefore, it fits best under Governance Information (CGR) as it details internal rules and procedures related to annual report disclosure responsibilities and accountability.
2025-12-09 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.